Patents by Inventor Geoffrey L. Turner

Geoffrey L. Turner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20020069049
    Abstract: A language-specific output structure on an output medium, and an associated language database structure, method, and computer system. An algorithm determines a preferred language of the user. Then the algorithm retrieves text in the preferred language from the language database structure, and transfers the text to output zones of the output medium.
    Type: Application
    Filed: December 6, 2000
    Publication date: June 6, 2002
    Inventor: Geoffrey L. Turner
  • Patent number: 5556978
    Abstract: 1R-cis, 1'R-cis isomer of a 2',2'-(3,11-dioxo-4,10-dioxatridecylene)-bis-(1,2,3,4-tetrahydro-6,7-dimet hoxy-2-methyl-1-veratrylisoquinolinium) salt, substantially free from other geometrical and optical isomers thereof. The 1R-cis,1'R-cis isomer has been found to have an advantageous combination of pharmacological properties, notably greater neuromuscular blocking potency, weaker histamine-releasing potency, and at equivalent levels of neuromuscular blockade, fewer potential adverse effects on the autonomic nervous system (sympathetic and parasympathetic blockade), in comparison with the known mixture of geometrical and optical isomers.
    Type: Grant
    Filed: March 28, 1995
    Date of Patent: September 17, 1996
    Assignee: Glaxo Wellcome Inc.
    Inventors: Derek A. Hill, Geoffrey L. Turner
  • Patent number: 5453510
    Abstract: 1R-cis,1'R-cis isomer of a 2',2'-(3,11-dioxo-4,10-dioxatridecylene)-bis(1,2,3,4-tetrahydro-6, 7-dimethoxy-2-methyl-1-veratrylisoquinolium) said, substantially free from other geometrical and optical isomers thereof. The 1R-cis,1'R-cis isomer has been found to have an advantageous combination of pharmacological properties, notably greater neuromuscular blocking potency, weaker histamine-releasing potency, and at equivalent levels of neuromuscular blockade, fewer potential adverse effects on the autonomic nervous system (sympathetic and parasympathetic blockage), in comparison with the known mixture of geometrical and optical isomers.
    Type: Grant
    Filed: July 10, 1992
    Date of Patent: September 26, 1995
    Assignee: Burroughs Wellcome Co.
    Inventors: Derek A. Hill, Geoffrey L. Turner